Advanced Imaging: Revolutionizing Gynecologic Oncology Outcomes
*Corresponding Author: Dr. Maria Lopez, University of Barcelona, Spain, Email: marialopez@gmail.comReceived Date: Jun 04, 2025 / Published Date: Jun 30, 2025
Citation: Lopez DM (2025) Advanced Imaging: Revolutionizing Gynecologic Oncology Outcomes. Current Trends Gynecol Oncol 10: 276.
Copyright: 漏 2025 Dr. Maria Lopez This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Innovations in gynecologic tumor imaging are transforming diagnosis, staging, and treatment monitoring. MRI, CT, DWI, and CEUS enhance tissue characterization and early recurrence detection. PET/CT with 18F-FDG is vital for metabolic assessment. Radiomics and AI facilitate personalized medicine by predicting outcomes. AI improves diagnostic accuracy and workflow, while radiomics aids in lesion differentiation and prognosis. DWI and CEUS provide crucial cellular and vascular insights. 18F-FDG PET/CT is essential for staging and response evaluation. MRI and CT offer detailed anatomical information and staging support. Hybrid imaging combines anatomical and functional data for comprehensive assessments.

